Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer.
Nature. 2020 Dec;588(7839):693-698. doi: 10.1038/s41586-020-2911-7. Epub 2020 Nov 11.
Nature. 2020.
PMID: 33177715